Jump to content

ATC code H03

From Wikipedia, the free encyclopedia

ATC code H03 Thyroid therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup H03 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH03.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

H03A Thyroid preparations

[edit]
H03AA01 Levothyroxine sodium
H03AA02 Liothyronine sodium
H03AA03 Combinations of levothyroxine and liothyronine
H03AA04 Tiratricol
H03AA05 Thyroid gland preparations
H03AA51 Levothyroxine sodium and iodine compounds

H03B Antithyroid preparations

[edit]
H03BA01 Methylthiouracil
H03BA02 Propylthiouracil
H03BA03 Benzylthiouracil

H03BB Sulphur-containing imidazole derivatives

[edit]
H03BB01 Carbimazole
H03BB02 Thiamazole
H03BB52 Thiamazole, combinations
H03BC01 Potassium perchlorate

H03BX Other antithyroid preparations

[edit]
H03BX01 Diiodotyrosine
H03BX02 Dibromotyrosine

H03C Iodine therapy

[edit]

H03CA Iodine therapy

[edit]

References

[edit]
  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code H03". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QH03". WHO Collaborating Centre for Drug Statistics Methodology.